Research > ETFs > ETF / ETP Commentary > 

Get Quantum Computing Exposure in THNQ

Artificial intelligence and the investment in its trends and innovators has been the key driver of stock market growth in 2025. Companies from nearly every segment see value in AI technologies, offering some powerful boons for investors with AI exposure in their portfolios. That’s before including the specific firms driving innovation in artificial intelligence. Those firms are in an “AI arms race” that includes quantum computing, with IBM the latest to stake its claim.See more: Robotics Expert Illah Nourbakhsh on AI & the Future of Work IBM (IBM) announced this past week that its quantum computing error correction algorithm can run on standard Advanced Micro Devices (AMD) processing chips. That news not only indicates a major step forward for IBM, but for quantum computing more generally.  Should the firm be correct that its research shows it can solve common quantum computing problems, that would push the entire segment forward. More than that, however, that common AMD chips can run that program represents a major step forward for quantum computing. “Implementing it, and showing that the implementation is actually 10 times faster than what is needed, is a big deal,” IBM director of research Jay Gambetta told Reuters.Quantum Computing Takes Big Step ForwardThe possible leap in processing power brought by quantum computers could turbocharge  AI innovation. Already, in 2024, some AI programs were leveraging quantum computing “transformers” to potentially analyze problems in chemistry and encryption. The ROBO Global Artificial Intelligence ETF (THNQ B-) offers exposure to IBM as one of numerous companies tied to the AI growth narrative. The strategy tracks the ROBO Global Artificial Intelligence Index. In doing so, the fund invests in both AI innovators and firms poised to benefit from advances in the transformational technology. The strategy also offers exposure to /AMD which could also benefit from this quantum computing news. Together, that has helped the AI-focused ETF return 19.2% over the last three months as of October 23rd. That has outperformed the fund’s ETF Database Category in that time. What’s more, the strategy has also outperformed over one, three, and five year periods, as well. The fund could present an appealing option for those looking to add AI innovation from another angle to their portfolios. To learn more about the next phase of AI, join our upcoming webcast on November 10 at 11 a.m. ET, “Now & Later: Phases of AI and Its Real-World Applications.” Register here. For more news, information, and analysis, visit the Artificial Intelligence Content Hub. Looking for regular updates? Subscribe here for weekly insights on robotics, AI, and healthcare technology, delivered straight to your inbox. The ROBO Global Artificial Intelligence Index is the underlying index for the ROBO Global Artificial Intelligence ETF (THNQ) and the L&G Artificial Intelligence UCITS ETF (AIAI.LN). vettafi.com is owned by VettaFi LLC (“VettaFi”). VettaFi is the index provider for THNQ ETF and AIAI.LN, for which it receives an index licensing fee. However, THNQ ETF and AIAI.LN are not issued, sponsored, endorsed, or sold by VettaFi. VettaFi and its affiliates have no obligation or liability in connection with the issuance, administration, marketing, or trading of THNQ ETF and AIAI.LN.

Performance data shown is past performance and is no guarantee of future results. Current performance may be higher or lower than the performance data quoted. Yield and return will vary, therefore you have a gain or loss when you sell your shares. For standard quarterly performance, go to the fund's Snapshot page by clicking on the ETF/ETP's symbol.

ETFs may trade at a premium or discount to their NAV and are subject to the market fluctuations of their underlying investments.

For iShares ETFs, Fidelity receives compensation from the ETF sponsor and/or its affiliates in connection with an exclusive long-term marketing program that includes promotion of iShares ETFs and inclusion of iShares funds in certain FBS platforms and investment programs. Please note, this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral. Additional information about the sources, amounts, and terms of compensation can be found in the ETF's prospectus and related documents. Fidelity may add or waive commissions on ETFs without prior notice. BlackRock and iShares are registered trademarks of BlackRock, Inc. and its affiliates.

FBS receives compensation from the fund's advisor or its affiliates in connection with a marketing program that includes the promotion of this security and other ETFs to customers ("Marketing Program"). The Marketing Program creates incentives for FBS to encourage the purchase of certain ETFs. Additional information about the sources, amounts, and terms of compensation is in the ETF's prospectus and related documents. Please note that this security will not be marginable for 30 days from the settlement date, at which time it will automatically become eligible for margin collateral.

News, commentary (including "Related Symbols") and events are from third-party sources unaffiliated with Fidelity. Fidelity does not endorse or adopt their content. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use.

Any data, charts and other information provided on this page are intended to help self-directed investors evaluate exchange traded products (ETPs), including, but limited to exchange traded funds (ETFs) and exchange traded notes (ETNs). Criteria and inputs entered, including the choice to make ETP comparisons, are at the sole discretion of the user and are solely for the convenience of the user. Analyst opinions, ratings and reports are provided by third-parties unaffiliated with Fidelity. All information supplied or obtained from this page is for informational purposes only and should not be considered investment advice or guidance, an offer of or a solicitation of an offer to buy or sell a particular security, or a recommendation or endorsement by Fidelity of any security or investment strategy. Fidelity does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating ETPs. Fidelity makes no guarantees that information supplied is accurate, complete, or timely, and does not provide any warranties regarding results obtained from their use. Determine which securities are right for you based on your investment objectives, risk tolerance, financial situation and other individual factors and re-evaluate them on a periodic basis.

Before investing in any exchange traded product, you should consider its investment objective, risks, charges and expenses. Contact Fidelity for a prospectus, offering circular or, if available, a summary prospectus containing this information. Read it carefully.